AGACNP Test #2 Questions With Correct
Answers
COPD - CORRECT ANSWER✔✔-a common preventable and treatable
| | | | | | | |
disease characterized by persistent airflow limitation, usually
| | | | | | |
progressive and associated with an enhanced chronic inflammatory
| | | | | | | |
response in the airways and the lung to noxious particles or gases.
| | | | | | | | | | |
Small Airways Disease - CORRECT ANSWER✔✔-Airway inflammation
| | | | | |
Airway fibrosis, luminal plugs
| | |
Increased airway resistance
| |
Parenchymal Destruction - CORRECT ANSWER✔✔-Loss of alveolar
| | | | | | |
attachments
Decrease of elastic recoil
| | |
Airflow limitation - CORRECT ANSWER✔✔-Small airways disease and
| | | | | | | |
parenchymal destruction |
Modified British Medical Research Council (mMRC) Questionnaire -
| | | | | | | |
CORRECT ANSWER✔✔-0. Not troubled with breathlessness except with
| | | | | | | |
strenuous exercise. |
,1. Troubled by shortness of breath when hurrying or walking up a slight
| | | | | | | | | | | | |
hill.
2. Walks slower than people of the same age due to breathlessness or
| | | | | | | | | | | | |
has to stop for breath when walking at own pace on the level.
| | | | | | | | | | | |
3. Stops for breath after walking ~100 m or after a few minutes on the
| | | | | | | | | | | | | | |
level.
4. Too breathless to leave the house or breathless when dressing or
| | | | | | | | | | | |
undressing.
GOLD 1: Mild - CORRECT ANSWER✔✔-FEV1 > 80% predicted
| | | | | | | |
GOLD 2: Moderate - CORRECT ANSWER✔✔-50% < FEV1 < 80%
| | | | | | | | | |
predicted
GOLD 3: Severe - CORRECT ANSWER✔✔-30% < FEV1 < 50% predicted
| | | | | | | | | |
GOLD 4: Very Severe - CORRECT ANSWER✔✔-FEV1 < 30% predicted
| | | | | | | | |
PFT classification of COPD - CORRECT ANSWER✔✔-In patients with
| | | | | | | | |
FEV1/FVC < 0.70: | |
Albuterol - CORRECT ANSWER✔✔-Short-acting beta2-agonists
| | | |
, Salmeterol, andacaterol - CORRECT ANSWER✔✔-Long-acting beta2-
| | | | |
agonists
Ipratropium - CORRECT ANSWER✔✔-Short-acting anticholinergics
| | | |
Tiotropium, aclidinium - CORRECT ANSWER✔✔-Long-acting
| | | | |
anticholinergics
theophylline - CORRECT ANSWER✔✔-Methylxanthines
| | |
beclomethasone - CORRECT ANSWER✔✔-Inhaled corticosteroids
| | | |
Milquetoast - CORRECT ANSWER✔✔-Phosphodiesterase-4 inhibitors
| | | |
The most common causes of COPD exacerbations - CORRECT
| | | | | | | | |
ANSWER✔✔-viral upper respiratory tract infections and infection of the
| | | | | | | | |
tracheobronchial tree. |
The goal of COPD treatment - CORRECT ANSWER✔✔-to minimize the
| | | | | | | | | |
impact of the current exacerbation and to prevent the development of
| | | | | | | | | | |
subsequent exacerbations.
|
Answers
COPD - CORRECT ANSWER✔✔-a common preventable and treatable
| | | | | | | |
disease characterized by persistent airflow limitation, usually
| | | | | | |
progressive and associated with an enhanced chronic inflammatory
| | | | | | | |
response in the airways and the lung to noxious particles or gases.
| | | | | | | | | | |
Small Airways Disease - CORRECT ANSWER✔✔-Airway inflammation
| | | | | |
Airway fibrosis, luminal plugs
| | |
Increased airway resistance
| |
Parenchymal Destruction - CORRECT ANSWER✔✔-Loss of alveolar
| | | | | | |
attachments
Decrease of elastic recoil
| | |
Airflow limitation - CORRECT ANSWER✔✔-Small airways disease and
| | | | | | | |
parenchymal destruction |
Modified British Medical Research Council (mMRC) Questionnaire -
| | | | | | | |
CORRECT ANSWER✔✔-0. Not troubled with breathlessness except with
| | | | | | | |
strenuous exercise. |
,1. Troubled by shortness of breath when hurrying or walking up a slight
| | | | | | | | | | | | |
hill.
2. Walks slower than people of the same age due to breathlessness or
| | | | | | | | | | | | |
has to stop for breath when walking at own pace on the level.
| | | | | | | | | | | |
3. Stops for breath after walking ~100 m or after a few minutes on the
| | | | | | | | | | | | | | |
level.
4. Too breathless to leave the house or breathless when dressing or
| | | | | | | | | | | |
undressing.
GOLD 1: Mild - CORRECT ANSWER✔✔-FEV1 > 80% predicted
| | | | | | | |
GOLD 2: Moderate - CORRECT ANSWER✔✔-50% < FEV1 < 80%
| | | | | | | | | |
predicted
GOLD 3: Severe - CORRECT ANSWER✔✔-30% < FEV1 < 50% predicted
| | | | | | | | | |
GOLD 4: Very Severe - CORRECT ANSWER✔✔-FEV1 < 30% predicted
| | | | | | | | |
PFT classification of COPD - CORRECT ANSWER✔✔-In patients with
| | | | | | | | |
FEV1/FVC < 0.70: | |
Albuterol - CORRECT ANSWER✔✔-Short-acting beta2-agonists
| | | |
, Salmeterol, andacaterol - CORRECT ANSWER✔✔-Long-acting beta2-
| | | | |
agonists
Ipratropium - CORRECT ANSWER✔✔-Short-acting anticholinergics
| | | |
Tiotropium, aclidinium - CORRECT ANSWER✔✔-Long-acting
| | | | |
anticholinergics
theophylline - CORRECT ANSWER✔✔-Methylxanthines
| | |
beclomethasone - CORRECT ANSWER✔✔-Inhaled corticosteroids
| | | |
Milquetoast - CORRECT ANSWER✔✔-Phosphodiesterase-4 inhibitors
| | | |
The most common causes of COPD exacerbations - CORRECT
| | | | | | | | |
ANSWER✔✔-viral upper respiratory tract infections and infection of the
| | | | | | | | |
tracheobronchial tree. |
The goal of COPD treatment - CORRECT ANSWER✔✔-to minimize the
| | | | | | | | | |
impact of the current exacerbation and to prevent the development of
| | | | | | | | | | |
subsequent exacerbations.
|
